The market-making platform for essential medicines
Kestrian is building a new infrastructure layer for the global generics market — focused on continuity, resilience, and control of flow.
Early Visibility into Supply Disruption
Kestrian focuses on identifying supply stress before it becomes visible to the wider system. By monitoring a range of upstream, regulatory, and operational signals, we build early awareness of emerging disruption across essential medicines. This allows risks to be addressed proactively, rather than reactively, when conventional procurement and distribution mechanisms are already under pressure.
Regulatory Routing Across Multiple Jurisdictions
Medicines do not move freely across borders without regulatory coordination. Kestrian is designed to operate across multiple regulatory regimes, enabling supply to be redirected lawfully and efficiently when disruptions arise. This cross-jurisdictional capability allows continuity to be maintained even when local supply pathways are constrained or fail entirely.
Optionality on APIs and Manufacturing Capacity
Resilient supply depends on access to alternatives when primary routes fail. Kestrian maintains optionality across critical inputs and manufacturing capacity, ensuring that dependence on any single source or facility is minimised. This flexibility supports continuity during periods of instability without relying on large-scale ownership of manufacturing assets.
Control of Selective Regulatory and Operational Chokepoints
In regulated supply chains, certain control points determine whether medicines can move or not. Kestrian focuses on selective regulatory and operational chokepoints that govern release, routing, and compliance. By ensuring control and readiness at these points, Kestrian can support continuity when standard systems are unable to respond quickly enough.